High Borrow Fee Alert
Sellas Life Sciences Group (SLS) has been identified by the Interactive Brokers Securities Lending Desk as having one of the highest borrow fees among stocks with a short value exceeding $1 million. High borrow fees are often indicative of a 'hard-to-borrow' status, where demand from short sellers significantly outstrips the available supply of shares. Traders should exercise caution, as elevated borrow costs can lead to increased volatility and potential short squeeze risks if the stock price begins to trend upward, forcing short sellers to cover their positions.
Signal data sourced from Interactive Brokers. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.